This week sees the publication of two large phase III randomized controlled trials of inhaled aztreonam in bronchiectasis. The global studies investigated whether patients with chronic Gram-negative …

Read more...

 A record number of abstracts featuring bronchiectasis are presented the ERS 2014 meeting. Below is a list of some of the key sessions featuring bronchiectasis abstracts

Room B2-1 Session 54 …

Read more...

Congratulations to EMBARC's Felix Ringshausen for today winning the ERS best abstract award for his study

"Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis"

The …

Read more...

The European Bronchiectasis Network (EMBARC) seeks to promote clinical research in bronchiectasis and to build research capacity in Europe. A key task in this will be identifying the areas of …

Read more...

The EMBARC registry is now open for registration. Centres are able to sign up to participate in the EU wide registry of non-CF bronchiectasis. Instructions on how to register and to access the CRF …

Read more...

International bronchiectasis researchers reported new data at the American Thoracic Society 2014 conference last week, with important new work in bronchiectasis reported. Highlights of two …

Read more...

A randomized controlled trial from investigators in Australia suggests that 8 weeks of supervised exercise training can reduce the frequency of exacerbations in patients with bronchiectasis. Previous …

Read more...

The European Respiratory Society has recognised EMBARC by awarding the European Bronchiectasis Network status as an official Clinical Research Collaboration (CRC). The three year partnership with the …

Read more...

Over 100 investigators and centres in 21 countries have now joined the EMBARC network. The participation of so many enthusiastic researchers across Europe will ensure the success of the EMBARC …

Read more...